Valine

Valine

SCHEMBL7458114

CC(C)[C@H](N)C(=O)O.NNC=O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.68
SLC1A3 P43003 5/20 0.41
SLC1A2 P43004 5/20 0.41
SLC1A1 P43005 5/20 0.41
DPP4 P27487 1/20 0.36
FAP Q12884 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRB2 P47870 2/20 0.33
GABRA4 P48169 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL2875734 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL1729111 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL29008223 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL3286146 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL10725920 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL30548418 0.83 SLC7A5 (0.79) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL1813972 0.83 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1DPP4
Valine SCHEMBL8516 0.83
Valine SCHEMBL43678 0.83
Valine SCHEMBL288203 0.83 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947510-B1 Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts BASF AG (DE) 2002-02-13 EP disclosed
EP-0947510-A1 Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts BASF AKTIENGESELLSCHAFT (DE) 1999-10-06 EP disclosed